These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32736940)

  • 1. Intussusception and Kawasaki disease after rotavirus vaccination in Taiwanese infants.
    Huang WT; Juan YC; Liu CH; Yang YY; Chan KA
    Vaccine; 2020 Sep; 38(40):6299-6303. PubMed ID: 32736940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety study of live, oral human rotavirus vaccine: A cohort study in United States health insurance plans.
    Hoffman V; Abu-Elyazeed R; Enger C; Esposito DB; Doherty MC; Quinlan SC; Skerry K; Holick CN; Basile P; Friedland LR; Praet N; Wéry S; Willame C; Dore DD; Rosillon D
    Hum Vaccin Immunother; 2018 Jul; 14(7):1782-1790. PubMed ID: 29533129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Intussusception After Oral Monovalent Rotavirus Vaccination in South Africa.
    Groome MJ; Tate JE; Arnold M; Chitnis M; Cox S; de Vos C; Kirsten M; le Grange SM; Loveland J; Machaea S; Maharaj A; Andrews N; Madhi SA; Parashar UD
    Clin Infect Dis; 2020 Apr; 70(8):1606-1612. PubMed ID: 31125061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intussusception risk after rotavirus vaccination in U.S. infants.
    Yih WK; Lieu TA; Kulldorff M; Martin D; McMahill-Walraven CN; Platt R; Selvam N; Selvan M; Lee GM; Nguyen M
    N Engl J Med; 2014 Feb; 370(6):503-12. PubMed ID: 24422676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants.
    Shui IM; Baggs J; Patel M; Parashar UD; Rett M; Belongia EA; Hambidge SJ; Glanz JM; Klein NP; Weintraub E
    JAMA; 2012 Feb; 307(6):598-604. PubMed ID: 22318281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Intussusception After Rotavirus Vaccination: Meta-analysis of Postlicensure Studies.
    Rosillon D; Buyse H; Friedland LR; Ng SP; Velázquez FR; Breuer T
    Pediatr Infect Dis J; 2015 Jul; 34(7):763-8. PubMed ID: 26069948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program.
    Carlin JB; Macartney KK; Lee KJ; Quinn HE; Buttery J; Lopert R; Bines J; McIntyre PB
    Clin Infect Dis; 2013 Nov; 57(10):1427-34. PubMed ID: 23964090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intussusception and Monovalent Rotavirus Vaccination in Singapore: Self-Controlled Case Series and Risk-Benefit Study.
    Yung CF; Chan SP; Soh S; Tan A; Thoon KC
    J Pediatr; 2015 Jul; 167(1):163-8.e1. PubMed ID: 25882872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil.
    Patel MM; López-Collada VR; Bulhões MM; De Oliveira LH; Bautista Márquez A; Flannery B; Esparza-Aguilar M; Montenegro Renoiner EI; Luna-Cruz ME; Sato HK; Hernández-Hernández Ldel C; Toledo-Cortina G; Cerón-Rodríguez M; Osnaya-Romero N; Martínez-Alcazar M; Aguinaga-Villasenor RG; Plascencia-Hernández A; Fojaco-González F; Hernández-Peredo Rezk G; Gutierrez-Ramírez SF; Dorame-Castillo R; Tinajero-Pizano R; Mercado-Villegas B; Barbosa MR; Maluf EM; Ferreira LB; de Carvalho FM; dos Santos AR; Cesar ED; de Oliveira ME; Silva CL; de Los Angeles Cortes M; Ruiz Matus C; Tate J; Gargiullo P; Parashar UD
    N Engl J Med; 2011 Jun; 364(24):2283-92. PubMed ID: 21675888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
    Soares-Weiser K; Maclehose H; Bergman H; Ben-Aharon I; Nagpal S; Goldberg E; Pitan F; Cunliffe N
    Cochrane Database Syst Rev; 2012 Nov; 11():CD008521. PubMed ID: 23152260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intussusception after monovalent rotavirus vaccine-United States, Vaccine Adverse Event Reporting System (VAERS), 2008-2014.
    Haber P; Parashar UD; Haber M; DeStefano F
    Vaccine; 2015 Sep; 33(38):4873-7. PubMed ID: 26276687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico.
    Velázquez FR; Colindres RE; Grajales C; Hernández MT; Mercadillo MG; Torres FJ; Cervantes-Apolinar M; DeAntonio-Suarez R; Ortega-Barria E; Blum M; Breuer T; Verstraeten T
    Pediatr Infect Dis J; 2012 Jul; 31(7):736-44. PubMed ID: 22695189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean.
    Velázquez RF; Linhares AC; Muñoz S; Seron P; Lorca P; DeAntonio R; Ortega-Barria E
    BMC Pediatr; 2017 Jan; 17(1):14. PubMed ID: 28086819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety profile of rotavirus vaccines among individuals aged ≥8 months of age, United States, vaccine adverse event reporting system (VAERS), 2006-2019.
    Haber P; Tate J; Marquez PL; Moro PL; Parashar U
    Vaccine; 2021 Jan; 39(4):746-750. PubMed ID: 33267969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012.
    Haber P; Patel M; Pan Y; Baggs J; Haber M; Museru O; Yue X; Lewis P; Destefano F; Parashar UD
    Pediatrics; 2013 Jun; 131(6):1042-9. PubMed ID: 23669521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
    Soares-Weiser K; Maclehose H; Bergman H; Ben-Aharon I; Nagpal S; Goldberg E; Pitan F; Cunliffe N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008521. PubMed ID: 22336845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intussusception risk after RotaTeq vaccination: evaluation from worldwide spontaneous reporting data using a self-controlled case series approach.
    Escolano S; Hill C; Tubert-Bitter P
    Vaccine; 2015 Feb; 33(8):1017-20. PubMed ID: 25596460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of post-licensure data on benefits and risks of vaccination to inform vaccine policy: The example of rotavirus vaccines.
    Parashar UD; Cortese MM; Payne DC; Lopman B; Yen C; Tate JE
    Vaccine; 2015 Nov; 33 Suppl 4():D55-9. PubMed ID: 26122581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmarketing evaluation of the short-term safety of the pentavalent rotavirus vaccine.
    Loughlin J; Mast TC; Doherty MC; Wang FT; Wong J; Seeger JD
    Pediatr Infect Dis J; 2012 Mar; 31(3):292-6. PubMed ID: 22173146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of Post-Licensure Data on Benefits and Risks of Vaccination to Inform Vaccine Policy: The Example of Rotavirus Vaccines.
    Parashar UD; Cortese MM; Payne DC; Lopman B; Yen C; Tate JE
    Am J Prev Med; 2015 Dec; 49(6 Suppl 4):S377-82. PubMed ID: 26590437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.